Greenwood Capital Associates LLC Amgen Inc Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Amgen Inc stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 52,096 shares of AMGN stock, worth $13.9 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares

52,096

Previous 42,225 23.38%

Holding current value

$13.9 Million

Previous $13.2 Million 27.23%

% of portfolio

2.22%

Previous 1.77%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$309.38 - $337.38 $3.05 Million - $3.33 Million	9,871 Added 23.38%	52,096 $16.8 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $1.96 Million - $2.39 Million	7,472 Added 21.5%	42,225 $13.2 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $3.65 Million - $4.41 Million	13,580 Added 64.14%	34,753 $9.88 Million
Q4 2023 Mar 05, 2024	SELL	$255.7 - $288.46 $11,762 - $13,269	-46 Reduced 0.22%	21,173 $6.1 Million
Q3 2023 Oct 18, 2023	SELL	$218.65 - $271.46 $60,566 - $75,194	-277 Reduced 1.29%	21,219 $5.7 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $413,755 - $489,257	1,931 Added 9.87%	21,496 $4.77 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $4.42 Million - $5.38 Million	19,565 New	19,565 $4.73 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $2.61 Million - $2.93 Million	-15,696 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $22,025 - $25,740	130 Added 0.84%	15,696 $2.68 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $169,633 - $189,532	-1,005 Reduced 6.06%	15,566 $2.71 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $2.77 Million - $3.17 Million	16,571	16,571 $3.09 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account

Greenwood Capital Associates LLC Amgen Inc Transaction History